Bryan K. Gathagan
CIK: 0001981919
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IMMUCELL CORP /DE/
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 12, 2025ICCC
IMMUCELL CORP /DE/
Purchase(P)Direct1K shares at avg. $6.32$6K - Apr 16, 2025ICCC
IMMUCELL CORP /DE/
Award(A)DirectNon Qualified Stock Options (Right to buy)
10K shares- - Sep 20, 2024ICCC
IMMUCELL CORP /DE/
Award(A)DirectNon-Qualified Stock Options (Right to buy)
10K shares at avg. $3.60-
1-3 of 3 transactions
About Gathagan Bryan K.
Gathagan Bryan K. (SEC CIK 0001981919) files insider reports with the SEC as Director of IMMUCELL CORP /DE/ (ICCC).
Signal8 holds 3 ownership filings by Gathagan Bryan K., all Form 4s, filed between Sep 24, 2024 and Apr 14, 2026. Those filings report 3 transactions, from Sep 20, 2024 to Jun 12, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Gathagan Bryan K.'s filings is in PORTLAND, ME.
Recent filings by Gathagan Bryan K.
Other insiders filing for IMMUCELL CORP /DE/ (ICCC)
- te Boekhorst Paul Francis Olivier, President and CEO
- DiMarco Anthony, Director
- Guillemette Gilles, Director
- Turner Kathy V, Director
- Tomsche David Scott, Director
- Basse Gloria F, Director